Pharmacolog has registered DrugLog® with the US Food and Drug Administration (FDA) and can thereby sell and deliver systems to the US market.
DrugLog® is used to verify the identity and concentration of injectable drugs prior to administration for increased patient safety and has been sold in Europe since 2017. The system is classified as a Class 1 Medical Device and has undergone special tests required for registration with the US Food and Drug Administration (FDA) in the North American market. With the registration with the FDA, the product is now approved for sale in the U.S. as well. Pharmacolog are currently successfully selling their WasteLog® system in the USA. That product is intended to monitor and secure residual drug-classified preparations and is classified as a laboratory instrument without FDA registration requirements.
CEO, Mats Högberg comments: “Interest in DrugLog has steadily increased from the US market as we have been selling and promoting WasteLog. When customers understand the principle behind WasteLog, they realize that the technology also can be used for quality control of prepared drugs. Something our partner Codonics also noted during the launch of WasteLog. Right now, a lot is happening in the US market to improve the handling of medicines and we are therefore very happy to be able to offer DrugLog to hospitals and hospital pharmacies in the USA.”
For more information contact:
Mats Högberg, CEO
Phone: +46 70-546 50 21
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.